US Retail Pharmacy Market Size, Share, Growth and Forecast, 2025-2035

What counts as a drugstore and pharmacy counter sale

The U.S. retail pharmacy market was valued at USD 493.93 billion in 2025 and is projected to increase from USD 513.73 billion in 2026 to USD 731.84 billion by 2035, registering a CAGR of 4.01% during 2026–2035. Demand comes from an aging patient base, weight-loss and diabetes prescriptions, and vaccines and clinical services delivered at the counter. South held the largest regional share, 39.0% in 2025, and it is also the fastest-growing region at 4.38% a year. The structure of the industry changed sharply after Rite Aid closed its stores and Walgreens moved into private ownership in 2025, which pushed prescription files toward surviving chains and independent owners. Federal pricing has become the main commercial variable, because negotiated Medicare prices took effect in January 2026 while a new law signed in February 2026 changes how benefit managers are paid from 2028.

How big is the U.S. retail pharmacy industry and what does it count?

The market counts sales of prescription and over-the-counter medicines, along with paid clinical services, at chain drugstores, grocer and mass-merchant counters, independent stores, hospital outpatient counters and consumer mail or online orders. Value is measured at the point of sale to patients and payers. The United States has about 51,000 retail locations, a figure derived from the National Community Pharmacists Association count of 18,988 independents representing about 37% of the total.

The estimate excludes central-fill specialty dispensing by benefit manager affiliates, long-term care dispensing and drugs administered in hospitals. Those channels explain why total dispensing revenue across all pharmacy types, which Drug Channels reported as up 10% for 2025, runs well above this market. General merchandise sold in drugstores falls outside the estimate as well, except for health and personal care items sold beside the counter.

Chain counters and branded prescriptions carry the value

Chains hold the counter while online orders grow fastest

Based on type of pharmacy, the market is categorized into chain, independent, hospital, mail order and online pharmacies. Chain Pharmacies led with 69.0% of 2025 value because CVS Health runs about 9,000 retail locations and Walmart reported nearly 4,600 pharmacies in an April 2026 release. Independents remain significant, with the National Community Pharmacists Association estimating 18,988 stores and USD 103 billion in 2025 sales. Online Pharmacies grow fastest at 9.03% a year as Amazon Pharmacy adds about 2,000 same-day communities during 2026, according to its Feb. 11, 2026 release.

Prescriptions dominate as cough and cold units slip

Based on type of prescription, the market is categorized into prescription drugs and over-the-counter drugs. Prescription Drugs (Rx) led with 90.0% of 2025 value because the National Community Pharmacists Association reports that over 96% of independent sales come from prescriptions. The same group also grows fastest at 4.12% a year, as the Medicare GLP-1 Bridge opened weight-loss coverage to eligible enrollees on July 1, 2026, according to the Medicare Rights Center. Nonprescription medicines move more slowly because Consumer Healthcare Products Association data show units falling from 6,197 million in 2020 to 5,668 million in 2023.

Branded drugs hold the value while generics fill the volume

Based on product type, the market is categorized into branded drugs and generic drugs. Branded Drugs led with 78.0% of 2025 value because generics and biosimilars filled 90% of 2024 prescriptions yet took only 12% of drug spending, according to the Association for Accessible Medicines in September 2025. Generic Drugs grow fastest at 4.71% a year as new launches reach the counter, and CVS Health named generic introductions among its revenue pressures in its third-quarter 2026 filing. Biosimilars add to that shift, having saved USD 56.2 billion since 2015 on the same association figures.

Dispensing pays the bills as chronic care services expand

Based on service offered, the market is categorized into medication dispensing, vaccination services, consultation and counseling, chronic disease management and health screenings. Medication Dispensing led with 88.0% of 2025 value because CMS counted USD 467.0 billion in 2024 national prescription spending, which dwarfs paid clinical work. Chronic Disease Management grows fastest at 6.45% a year as owners broaden their clinical work, and the 2026 National Community Pharmacists Association Digest shows 81% offering medication therapy management and 62% monitoring blood pressure. Vaccination remains the best-established service, with 91% of independents offering flu shots.

Older patients and GLP-1 volume lift prescription counts

An older population fills more prescriptions each year

Aging is the steadiest source of counter volume, because older patients take more maintenance medicines and visit more often. The Census Bureau reported in June 2025 that the population aged 65 and older rose 3.1% to 61.2 million in 2024, reaching 18.0% of residents. Older adults already outnumber children in 11 states, including Florida and Pennsylvania. CMS data point the same way, since Medicare drug spending grew at its fastest pace in more than a decade in 2024, according to Drug Channels in February 2026. As a result, public programs now pay 51.2% of net outpatient drug spending, which ties store revenue closely to Medicare enrollment.

GLP-1 prescriptions add value at a historic pace

Diabetes and weight-loss medicines have become the largest single source of new counter revenue. Drug Channels estimated in March 2026 that GLP-1 dispensing accounted for about 60% of retail revenue growth over the past five years. CMS reported that demand for these drugs partly offset slower growth in 2024, when prescription spending rose 7.9% to USD 467.0 billion. Federal coverage is now widening the patient pool, because the Medicare GLP-1 Bridge began on July 1, 2026 with a USD 50 monthly copay and runs through Dec. 31, 2027. In turn, Walgreens pharmacists are explaining eligibility and connecting patients with prescribers, according to Fierce Healthcare.

Download Free Sample

Pharmacists are taking on vaccines and point-of-care tests

Clinical work brings patients to the counter and adds fees that do not depend on drug reimbursement. A CDC report dated Jan. 23, 2026, cited by Pharmacy Times, found pharmacies and drugstores were the most common nonmedical vaccination setting in 2023-2024, at 71.5% for COVID-19, 81.7% for RSV and 48.0% for influenza. State rules are widening this role, since North Carolina standing orders let retail pharmacists test and treat flu in patients aged 5 and older from Oct. 1, 2025. Independent owners have moved too, with 91% offering flu immunization in 2025 under the NCPA 2026 Digest. Therefore, Chronic Disease Management grows fastest within the services group.

Closed Rite Aid stores send prescriptions to survivors

Consolidation is moving existing patients rather than removing them, which lifts volume per surviving store. The Associated Press reported in October 2025 that CVS Health transferred files from 626 Rite Aid pharmacies in 15 states and kept running 63 former locations. That volume shows up in filings, because the CVS Health third-quarter 2026 filing reports same-store prescription volume up 5.8% over nine months on a 30-day equivalent basis. Drug Channels counts more than 6,000 locations bought by CVS Pharmacy and Walgreens from smaller rivals between 2010 and 2025. As a result, Chain Pharmacies kept 69.0% of 2025 value despite shrinking store networks.

Same-day delivery and smaller stores redraw access

Shift to same-day prescription delivery across the country

Delivery has moved from a mail-order convenience to a direct contest for the routine refill. Amazon Pharmacy said on Feb. 11, 2026 that same-day service will reach nearly 4,500 cities and towns by the end of the year, including new service in Idaho and Massachusetts. Walmart answered in September 2025 by adding refrigerated and reconstituted medicines such as insulin and GLP-1 drugs, and it says it now delivers more than 90% of prescription medications. This competition supports demand for prescription delivery services beyond chain stores. In turn, Online Pharmacies post the fastest type growth, 9.03% a year, though stores still handle most refills today.

Rise of small pharmacy-only stores after years of closures

Chains are rethinking the large front-of-store box after a long period of shrinkage. Bisnow reported on March 31, 2026 that CVS Health closed more than 1,100 stores from 2022 through 2025 but now plans about 60 openings in 2026, including 20 pharmacy-only stores of around 3,000 square feet. The first of these opened in Chicago on March 30, 2026. Weak front-end sales help explain the change, since Consumer Healthcare Products Association figures show unit declines across three years to 2023. As a result, future counters will rely less on general merchandise and more on prescriptions, which already hold 90.0% of 2025 value in the Credence Research model.

Download Free Sample

Opportunity in cash-pay GLP-1 and direct price programs

Cash-pay programs offer an opening for pharmacies that can serve patients without insurance coverage for weight-loss medicines. TrumpRx launched on Feb. 5, 2026 with more than 40 discounted drugs, and Pharmaceutical Technology reported a Wegovy pill price of USD 149 a month and pharmacy coupons for the Wegovy pen. Walmart moved on the same demand in April 2026 by adding virtual care, nutrition and pharmacist support around GLP-1 treatment across nearly 4,600 pharmacies. Amazon Pharmacy also lists the Wegovy pill from USD 149 for cash payers. Consequently, counters that pair coupons with counseling can win refills, and this supports Chronic Disease Management growth of 6.45% a year.

Opportunity for independents as chains leave neighborhoods

Chain exits leave patients looking for a nearby counter, which gives independent owners a practical opening. The National Community Pharmacists Association estimates independents edged up from 18,960 stores in 2025 to 18,988 in 2026, even as Rite Aid disappeared. Federal law now strengthens their position, because Pharmacy Times reports that the act signed on Feb. 3, 2026 requires Part D sponsors to admit any willing pharmacy from 2029 and creates protections for essential retail pharmacies in underserved areas. Branded franchise programs give small owners scale as well, with ScrapeHero counting about 4,275 Health Mart and 2,352 Good Neighbor Pharmacy locations in March 2026. Independent owners can therefore defend a local patient base ahead of the 2029 network rule.

Negotiated prices and reimbursement squeeze store margins

Negotiated Medicare prices strain pharmacy cash flow

Maximum fair prices took effect in January 2026, and refunds now arrive well after pharmacies pay wholesalers. A National Community Pharmacists Association survey of more than 500 owners, released Feb. 27, 2026, found 67% wait 22 or more days for refunds, while wholesalers often expect payment in about 14 days. In addition, 64% were considering refusing to stock these drugs. Another 15 drugs join the program in January 2027, so owners need faster refund rules.

Volume grows while same-store sales and prices fall

Higher prescription counts no longer guarantee higher revenue, as federal and company data now show. CVS Health reported third-quarter 2026 pharmacy same-store sales down 0.6% despite same-store prescription volume up 3.9%, citing regulatory price cuts and reimbursement pressure. Census Bureau store sales for January through August 2026 ran about 2.1% below the same months of 2025. The White House cited Bureau of Labor Statistics data in November 2026 showing prescription prices down 4.5%, so chains must lower dispensing costs.

Store closures widen gaps in local access

Closures hurt patients in neighborhoods where no replacement counter opens, and independents carry the greater risk. A study in Health Affairs, published in December 2024, found 29.4% of the 88,930 pharmacies operating from 2010 to 2020 had closed by 2021, with independents at higher risk than chains. Rite Aid had around 1,200 stores before its final 2025 shutdown, according to the Associated Press. Delivery services can fill part of this gap, though patients needing vaccines or counseling still require a physical location nearby.

Benefit manager rules arrive years after the damage

Reimbursement reform will not relieve current margins, because the main provisions start only in 2028 and 2029. The law signed on Feb. 3, 2026 delinks Part D benefit management pay from drug prices, yet Bisnow reports that insurers had already slashed reimbursement before CVS Health closed over 1,100 stores. Independent volume is slipping too, with the 2026 National Community Pharmacists Association Digest showing 65,795 prescriptions per store in 2025 against 67,601 in 2024. Owners must therefore renegotiate contracts while waiting for federal standards due in April 2028.

The South leads on store count and older residents

The South leads on Florida and Texas store networks

The South held 39.0% of 2025 value and grows at 4.38% a year, the fastest pace among the four regions. ScrapeHero's March 2026 dataset of 30,145 tracked locations lists 3,243 in Florida and 2,323 in Texas, with Georgia at 1,125 and North Carolina at 930. Florida is also among the 11 states where older adults outnumber children, according to the Census Bureau. Policy is active as well, because North Carolina standing orders opened flu test-and-treat services to pharmacists in October 2025.

The West combines California scale with thin rural coverage

The West held 23.0% of 2025 value and grows at 4.08% a year. California alone shows 2,876 locations in the March 2026 ScrapeHero dataset, which tracks only part of the national store base. Rural gaps shape the rest of the region, since Amazon Pharmacy cites Navajo Nation communities where the nearest store can be a 45 to 60 minute drive. CVS Health also runs former Rite Aid and Bartell Drugs locations in Idaho, Oregon and Washington, according to the Associated Press.

Download Free Sample

The Midwest tests new formats from Chicago outward

The Midwest held 20.0% of 2025 value and grows at 3.68% a year. Illinois has 1,023 pharmacy locations and Michigan has 916 in the March 2026 ScrapeHero count, which places both among the larger state networks. The region is also a testing ground for store design, because CVS Health opened its first pharmacy-only store in Chicago on March 30, 2026. Delivery reaches its edges too, with Amazon Pharmacy describing prescriptions sent to Mackinac Island in Michigan by ferry and horse.

The Northeast is dense, older and slower growing

The Northeast held 18.0% of 2025 value and grows at 3.48% a year, the slowest pace among the four regions. New York has 1,529 pharmacy locations in the March 2026 ScrapeHero count. Age supports refills here, since the Census Bureau lists Maine, New Hampshire, Pennsylvania, Rhode Island and Vermont among the states where older adults outnumber children. However, Rite Aid was concentrated on the East Coast before it closed, according to the Associated Press, and Amazon Pharmacy named Massachusetts among its 2026 additions.

Download Free Sample

Dated moves that reset the chain landscape since 2025

Delivery, kiosks and refund systems change the counter

• Same-day cold chain delivery now covers insulin and GLP-1 drugs at Walmart, which added refrigerated and reconstituted medicines in September 2025.
• Pickup kiosks sit in a Los Angeles One Medical lobby for Amazon Pharmacy customers, and the company plans more of them during 2026.
• The Medicare Transaction Facilitator routes negotiated price refunds to pharmacies, and 78% of owners surveyed by the National Community Pharmacists Association reported problems reconciling those claims.
• Dispensing automation matters more as CVS Health same-store volume rises while sales fall, because lower labor cost per fill protects margin at the counter.

Two chains and Walmart face a new delivery rival

Competition centers on who keeps the prescription relationship as store networks shrink. CVS Health operates about 9,000 retail locations and absorbed prescription files from 626 Rite Aid stores. Walgreens, private since Aug. 28, 2025, remains the second-largest network with 8,084 locations in the March 2026 ScrapeHero count. Walmart competes on price and grocery baskets across nearly 4,600 pharmacies, while Amazon Pharmacy competes on delivery speed and automatic coupons. Independents compete on service, often through Health Mart or Good Neighbor Pharmacy programs. Drug Channels reports that CVS Health, Walgreens, Cigna and UnitedHealth Group together took more than half of all U.S. dispensing revenue in 2025, and the top 15 took nearly three-quarters. Chain-level share by state is not officially published, so location counts remain the best public guide to local position. Rite Aid no longer competes after closing all of its stores.

Companies with verified U.S. store or delivery activity

Volume is healthy, while pricing decides who stays open

Credence Research's view is that U.S. retail pharmacy has a pricing problem rather than a demand problem. Prescription counts continue to rise, as CVS Health same-store volume shows, yet the same filing shows sales falling once regulated prices apply. Operators with low dispensing cost and strong clinical programs should keep their margins, while stores relying on reimbursement spread are exposed until the 2028 federal changes arrive. Delivery will also take routine refills away from weaker counters. The most important indicator to watch is therefore the gap between prescription volume and same-store sales during 2027.

How store sales and prescription data were modeled

The report uses 2025 as the base year, 2026 as the estimate year and 2035 as the forecast year. Market values come from the Credence Research model, checked against Census Bureau store sales, CMS spending data, company filings and pharmacy association reports. Segment and regional splits in this report are Credence Research estimates throughout. The research relied on public documents and databases only, and no interviews or surveys were conducted for this report.

Prescription volume outruns price cuts through 2035

Through 2035, the U.S. retail pharmacy business should benefit from an older patient base, and wider obesity coverage should keep prescription counts growing faster than prices. Near-term revenue will look weaker than volume, because 15 more negotiated drugs arrive in January 2027 and regulated price cuts continue to feed through store sales. From 2028, Part D benefit manager changes should improve contract terms, and the any willing pharmacy rule follows in 2029. Store numbers are unlikely to return to earlier levels, though smaller pharmacy-only formats and delivery should hold access together, particularly in the South, which remains the largest region.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.